Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It's cheaper to do the trial in Russia or why else would they be there? If they need a phase 3 it makes sense to have sites in place... Possibly they have a Russian partner lined up? We'll see after data is released... Leo should be calling India/Brazil for partnerships...
So has IPIX outstanding shares increased... Doubt anyone will pay more than 250 million which values the deal around 50 to 60 cents.
Wouldn't be surprised if IPIX gets sold after data... No doubt Leo froze all other activity and now waits to see how much he can get for B/K... Was hoping for a buck but will be happy with 50 cents... If data flops head for the hills.
By time B might be approved there will be little need in the US when high risk are vaccinated... Leo's only hope is India at-the-point... Unless they get emergency use, approval in 2022 will not be worth the cost of phase 3. Why Leo's been silent on post phase 2 plans and pushing the lab testing narrative...
IPIX partnering with an Indian Biotech would rally this to a dollar plus... The major problem is the deal maker. Only Alphasigma on his resume which is pending further advancement.
The main concern here is not B for C potential it's the 16 month inactivity for other projects? No hiring, no finance updates, no corporate updates, no SHer meetings... Just blah, blah, blah CV19... How can the trial fail now?
More fluff, back to sleep..... Great, the trial will complete eventually... Never any meaningful news like progress on other compounds, finance and plans past phase 2...
My guess, Leo recently used the the additional 2 million available from Kips which put them over the 5 percent reporting. Some here are suggesting they added shares? Of course, Leo needed 2 million more to survive past the upcoming storm. Why is the stock dropping lately? Low demand, plenty of inventory to dispose of...
IPIX was finished last Summer/Fall when they couldn't find a partner or Govt assistance. The RBL's 8 month of testing assured they'd be late to the party... Still today, this lame CEO has no plan past phase 2... Not once has he mentioned phase 3 or emergency use. All he reports on is continued testing "at the lab" for the next pandemic... Bringing in Kips Bay at 10 cents per/share showed how desperate they are...
Right now, Menon and Dr B are laughing their behinds off... Leo thought he could run a pretend biotech with no background.... Even the greatest data on the planet he ruined...
What can Leo possibly PR to rally the stock? He used up 40 plus PRs touting B for C. Show us the data after 15 months of hype... Obviously, nobody is impressed with the stock trading closer to year lows and still no partner or grant funding. Shareholders had several chances to sell above .40... Never trust a conman for a CEO!!!
How is it racist, Menon and Kumar are gone so it would have been an asset to have that nationality onboard since many keep posting virus figures from India.
Leo let his 2 Indian workers go... Does this pretend CEO do anything right?
18's are on the way, no stopping the slide... Still 2 1/2 months until judgement day.
Good to know there will be 20 million more shares sold when data is poor. My guess they'll be long gone before judgement day.
What'd sad is this has 8 more weeks to slide... The fluff news has no effect...
Leo did get another year's salary out of the COV19 drama... He surely didn't execute a proper plan for shareholder value. Many feared he would turn his last compound B into the ground... Let Pfizer pick up the sraps and move B along.
Close in the teens today, the boat sinks some more.
138 is a bogus number... From the same site that had the trial starting in December... 120 is it until Leo states differently and the official trial site FDA.GOV updates... Why would an additional 18 be needed anyway? Either they get emergency approval with 120 or need a phase 3. Also, that's if the data warrants further advancement.
.15 would be next leg down which is expected. Then the fun begins if the trial flops. 8 pennies then all time lows continuing. They have nothing else to rally the stock. The past 2 years has proven this.
Trial size is 120 how did they come up with 138 when Leo just announced 50 percent enrollment? Bogus site....
Over sold? It was over valued all along. Why should ipix be valued above 20 million? They have no structure or balance sheet. Just a continued dilution of the equity in the pennies.
This stock is finished put a fork in it. Leo did it again to the shareholders but there’s no rebounding this time. 3 times to 50 cents and now back to the teens. Get a good lawyer Leo!!!
Slide continues Leo can’t stop it. What a pump and dump operation.
There's zero logic to buy shares when there's no news until trial data. Why risk a drop to 8 pennies on poor results.... Can always buy back later.... All those who sold above .30 smart move.
Maxdud has been more correct than many of the true longs... What has Leo accomplished for shareholder value except more dilution? Artificial rise in market cap due to added shares... 100 million added the past year... To raise what? 12 million.... Sad
3 times the stock traded up to .50 only to see it trade back to the .20's... Eventually time will run out for another attempt... Nobody cares about IPIX... Reddit awareness backfired...
It's down because the trial is taking longer than expected, still sites not recruiting and there's no other business activity worth reporting... Nothing has changed except CV19 extended IPIX's life another year.
Will be interesting to see where this trades for results in August? Thought .15 would hold but looking like .10.
The plunge continues no end in site!!! Last PR continued the trend.
Ask .2165? Lowest in some time as today's fluff solidifies the decline. Leo has not learned one lesson on press release strategy. The stock will not climb with enrollment percentages or scheduled presentations...
19 subjects used for OM interim analysis? They should have close to 30 completed now which includes the evaluation period. Makes no sense for OM and not a pandemic situation.
presented below is information on Cellceutix’s clinical trial of Brilacidin for OM, including preliminary Interim Analysis of 19 patients (9 administered Brilacidin; 10 administered placebo) who have reached or passed the planned visit at the end of 5 weeks on study, and received a cumulative radiation dose of at least 55 Gy.
http://www.ipharminc.com/new-press-release/2017/3/26/cellceutix-reports-very-encouraging-interim-analysis-of-phase-2-drug-candidate-brilacidin-for-severe-oral-mucositis-om-in-head-and-neck-cancer-patients-high-potential-for-preventative--cyml9
Either way whether 60 or 120 are analyzed it's still not enough to get approval... The question going forward do they have a plan past P2? Right now appears no.... Turning into OM/Absssi if data is good, Prurisol if not...
Results by Sept or Oct? Your less generous than me... If they have to wait that long the entire 18 months on B to C is a waste of time... Each day as more and more get vaccinated diminishes the need for B on top of other treatments that are progressing... Pfizer new pill by 2022 and so on...
Your kidding right? So what's the strategy behind the trial? Proceed to phase 3 and get approval in mid 2022 or conquer the next pandemic in 2075? The reason the stock sits at toilet level is due to no strategy... They have no idea/plan past phase 2... New name change, Phase 2 Pharma... That's as far as ever go....
If recruitment is slow as it appears wouldn't 50 percent data analysis make sense for a pandemic? What's considered small? Heck, Didn't Leo run less than 10 subject trials for UP and K? Time is critical to know what potential you have, they've already spent 16 months on this project..
Must read on interim analysis.....
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052936/
If B was the holy grail "perceived by management" wouldn't a mid point check make sense rather than string this out another 3 months? If data is poor end the trial... This is from the same company that did a 4 patient trial with K...
Third US site still MIA? Wake us up in August Leo for results!!!
United States, Louisiana
IPI Investigator Site Not yet recruiting
Metairie, Louisiana, United States, 70006
TheDane, Your theory by time IPIX starts a phase 3 with thousands of subjects it could be a year or longer to complete? Less Cv19 patients harder to recruit... Exactly what the faithful want to read. I've been pointing this out for months… Only shot is emergency use and someone jumps in to assist financially.